Forecasts data is unavailable for this security.
Consensus recommendation
- 14-Dec-23
- 19-Sep-24
- 17-Oct-24
- 14-Nov-24
Select bar for recommendation details.
Recommendations | 14-Nov-24 | |
---|---|---|
Buy | 0 | |
Outperform | 0 | |
Hold | 4 | |
Sell | 0 | |
Strong Sell | 0 |
Share price forecast in USD
The 2 analysts offering 12 month price targets for Athira Pharma Inc have a median target of 0.55, with a high estimate of 0.600 and a low estimate of 0.50. The median estimate represents a -16.55% decrease from the last price of 0.6591.
High | -9.0% | 0.600 |
Med | -16.6% | 0.55 |
Low | -24.1% | 0.50 |
Earnings history & estimates in USD
The next earnings announcement is expected on Feb 20, 2025.
Average growth rate | +3.15% |
Average growth rate | -25.90% |
More ▼
Revenue history & estimates in USD
Average growth rate | 0.00% |
Average growth rate | 0.00% |
More ▼